EP1206249A4 - Hydrodynamically balancing oral drug delivery system - Google Patents

Hydrodynamically balancing oral drug delivery system

Info

Publication number
EP1206249A4
EP1206249A4 EP00949840A EP00949840A EP1206249A4 EP 1206249 A4 EP1206249 A4 EP 1206249A4 EP 00949840 A EP00949840 A EP 00949840A EP 00949840 A EP00949840 A EP 00949840A EP 1206249 A4 EP1206249 A4 EP 1206249A4
Authority
EP
European Patent Office
Prior art keywords
hydrodynamically
delivery system
drug delivery
oral drug
balancing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00949840A
Other languages
German (de)
French (fr)
Other versions
EP1206249A1 (en
Inventor
Naresh Talwar
John N Staniforth
Michael J Tobyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1206249A1 publication Critical patent/EP1206249A1/en
Publication of EP1206249A4 publication Critical patent/EP1206249A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP00949840A 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system Withdrawn EP1206249A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system
WOPCT/IB99/01386 1999-08-04
PCT/IB2000/001083 WO2001010419A1 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Publications (2)

Publication Number Publication Date
EP1206249A1 EP1206249A1 (en) 2002-05-22
EP1206249A4 true EP1206249A4 (en) 2004-12-22

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00949840A Withdrawn EP1206249A4 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country Link
EP (1) EP1206249A4 (en)
JP (1) JP2003506400A (en)
CN (1) CN1376059A (en)
AP (1) AP2002002410A0 (en)
AU (2) AU5060499A (en)
BR (1) BR0012981A (en)
CA (1) CA2378468A1 (en)
CZ (1) CZ2002415A3 (en)
EA (1) EA200200126A1 (en)
HK (1) HK1047226A1 (en)
HR (1) HRP20020108A2 (en)
HU (1) HUP0202497A3 (en)
IL (1) IL147966A0 (en)
MX (1) MXPA02001272A (en)
NZ (1) NZ516959A (en)
OA (1) OA12003A (en)
PL (1) PL353321A1 (en)
SK (1) SK1832002A3 (en)
TR (1) TR200200467T2 (en)
WO (2) WO2001010405A1 (en)
ZA (1) ZA200200926B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (en) * 2001-04-02 2004-11-17 삼아약품 주식회사 Rapidly dissolving tablet and process for preparing same
AU2002355686B2 (en) 2001-07-04 2007-11-29 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
BRPI0513846A (en) 2004-08-13 2008-05-20 Boehringer Ingelheim Int prolonged-release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method of manufacture thereof and use thereof
DE102004042139B4 (en) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Peroral dosage forms to achieve a retarding effect after drug intake with a meal
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US9301919B2 (en) 2005-12-22 2016-04-05 Oakwood Laboratories, Llc Sublimable sustained release delivery system and method of making same
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (en) 2007-03-02 2010-08-15 Farnam Co Inc SUSTAINED-RELEASE TABLETS CONTAINING WAX-LIKE MATERIAL
CN102202656A (en) 2008-08-15 2011-09-28 蒂宝制药公司 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders
JP2012500230A (en) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 Gastric retention drug release system and method and use thereof
AU2009301994B2 (en) 2008-10-08 2016-10-20 Bioplus Life Sciences Pvt. Ltd. Sustained release drug delivery system
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (en) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd Hard capsule
KR102241487B1 (en) 2013-02-20 2021-04-16 주식회사 종근당 Pharmaceutical composition consisting of sustained-release pellets
ES2761407T3 (en) * 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Quickly dispersible topiramate dosage form
CN103462917A (en) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 Antiviral acyclovir tablet and preparation method thereof
CN109561710A (en) * 2016-06-14 2019-04-02 普瑞特克微生物有限责任公司 Animal feed pellets comprising feed addictive, its preparation and application
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
CN107375287B (en) * 2017-08-22 2019-11-29 安徽省肿瘤医院 A kind of purposes of atropine sulfate in preparation treatment Primary Hepatic cancer drug
CN107349195A (en) * 2017-08-22 2017-11-17 安徽省肿瘤医院 A kind of Verapamil is preparing the purposes in treating metastatic hepatic carcinoma medicine
CN107441115A (en) * 2017-08-22 2017-12-08 安徽省肿瘤医院 A kind of purposes of Verapamil joint sodium acid carbonate in primary liver cancer medicine is prepared
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
JP7034343B2 (en) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー Self-regulating permeable gastric retention drug delivery system
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3909520A1 (en) * 1988-03-25 1989-10-05 Ciba Geigy Ag SOLID, FAST CLEARING PHARMACEUTICAL FORMS
WO1993013760A1 (en) * 1992-01-13 1993-07-22 Gerhard Gergely Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
GB2283172A (en) * 1993-10-29 1995-05-03 Scherer Ltd R P Gelatin capsules
EP0667151A1 (en) * 1994-02-08 1995-08-16 Hexal Pharma GmbH Oral drug formulation containing diclofenac Sodium
WO1996008238A1 (en) * 1994-09-14 1996-03-21 Glaxo Group Limited Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) * 1997-01-29 1998-07-30 Poli Industria Chimica S.P.A. Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) * 1997-07-23 1999-02-04 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5368861A (en) * 1989-10-26 1994-11-29 Nippon Shinyaku Co., Ltd. Gastric preparation with sustained release

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3909520A1 (en) * 1988-03-25 1989-10-05 Ciba Geigy Ag SOLID, FAST CLEARING PHARMACEUTICAL FORMS
WO1993013760A1 (en) * 1992-01-13 1993-07-22 Gerhard Gergely Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
GB2283172A (en) * 1993-10-29 1995-05-03 Scherer Ltd R P Gelatin capsules
EP0667151A1 (en) * 1994-02-08 1995-08-16 Hexal Pharma GmbH Oral drug formulation containing diclofenac Sodium
WO1996008238A1 (en) * 1994-09-14 1996-03-21 Glaxo Group Limited Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
WO1998032425A1 (en) * 1997-01-29 1998-07-30 Poli Industria Chimica S.P.A. Pharmaceutical formulations with delayed drug release
WO1999004765A2 (en) * 1997-07-23 1999-02-04 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0110419A1 *

Also Published As

Publication number Publication date
JP2003506400A (en) 2003-02-18
EP1206249A1 (en) 2002-05-22
AU774957B2 (en) 2004-07-15
AU6309900A (en) 2001-03-05
NZ516959A (en) 2003-10-31
CN1376059A (en) 2002-10-23
EA200200126A1 (en) 2002-10-31
PL353321A1 (en) 2003-11-17
IL147966A0 (en) 2002-09-12
HUP0202497A3 (en) 2004-05-28
ZA200200926B (en) 2002-11-27
OA12003A (en) 2006-04-18
BR0012981A (en) 2002-06-18
WO2001010419A1 (en) 2001-02-15
HUP0202497A2 (en) 2002-11-28
SK1832002A3 (en) 2002-08-06
HRP20020108A2 (en) 2003-12-31
CZ2002415A3 (en) 2002-08-14
MXPA02001272A (en) 2002-07-22
WO2001010405A1 (en) 2001-02-15
TR200200467T2 (en) 2002-08-21
AP2002002410A0 (en) 2002-03-31
CA2378468A1 (en) 2001-02-15
HK1047226A1 (en) 2003-02-14
AU5060499A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
HRP20020108A2 (en) Hydrodynamically balancing oral drug delivery system
GB9904629D0 (en) Oral drug delivery system
HK1072177A1 (en) Drug delivery device
AU7333601A (en) Drug delivery management system
AU2123200A (en) Drug delivery device
AU2002302890A1 (en) Hydrodynamically balancing oral drug delivery system with biphasic release
EP1061987A4 (en) Drug delivery system
AU3520900A (en) Implantable drug delivery system
EP1087753A4 (en) Targeted liposomal drug delivery system
EP0989878A4 (en) Drug delivery system
EP1021137A4 (en) Drug delivery system
GB2352314B (en) Delivery system
GB0011066D0 (en) Delivery system
GB0029843D0 (en) Drug delivery system
GB9930160D0 (en) Drug delivery
GB9914960D0 (en) Delivery system
AU2002210580A1 (en) Drug delivery system
GB9901133D0 (en) Drug delivery system
GB9902509D0 (en) Drug delivery system
GB9917470D0 (en) Medicament delivery system
GB9923273D0 (en) Medicament delivery system
GB9905134D0 (en) Medicament delivery system
GB9800835D0 (en) Drug delivery system
AU4808000A (en) Drug delivery system
GB9904304D0 (en) Drug delivery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020304

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI PAYMENT 20020304

A4 Supplementary search report drawn up and despatched

Effective date: 20041109

17Q First examination report despatched

Effective date: 20061211

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070301

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1047226

Country of ref document: HK